Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from ODT: In vitro and In vivo Oncology 

  • You have access
    Dosimetry study of a novel 177Lu-Labeled Heterodimer Agents Targeting both Somatostatin Receptor and Integrin αVβ3
    Linlin Li, Jialin Xiang, Xingtong Peng, Yuanyuan Jiang and Zhaohui Zhu
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251747;
  • You have access
    First-in-class Actinium-225 (Ac-225) antibody radioconjugate ATNM-400 exhibits potent anti-tumor activity in preclinical solid tumor models
    Denis Beckford, Sumit Mukherjee, Debbie Lewis, Jason Li, Dina Yang, Karina Peregrina, Amanda Chin, Monideepa Roy and Adeela Kamal
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251354;
  • You have access
    Granzyme B PET Imaging Enhances Belzutifan and KL201 Combination Therapy Using a Tumor Cell Membrane Nano-Loading Platform for Renal Cell Carcinoma
    Yuyue Hou and Xiaotian Xia
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251359;
  • You have access
    Fibroblast activation protein targeted radioligand therapy enhances the efficacy of immune checkpoint blockade by remodeling the tumor microenvironment
    So Suyeon, Ho rim Oh, Seok-yong Lee, Minji Kim, Jong hyun Lee, Jeeyun Kim, Jingjing Zhang, Xiaoyuan Chen, Keon wook Kang, Gi jeong Cheon and Hyewon Youn
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251673;
  • You have access
    Noninvasive evaluation of Trop2 expression using 64Cu-NOTA-Trodelvy-F(ab')2 in gastric cancer
    Wenpeng Huang, Xiaoyan Li, Molly Deluca, Jonathan Engle, Lei Kang and Weibo Cai
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251390;
  • You have access
    Assessing Subcellular Compartmentation of Glutaminolysis in Breast Cancer to Optimize PET Tracer Development and Utilization
    Pradeep Kumar, Hoon Choi, Austin Pantel, Hsiaoju Lee, David Mankoff, Rong Zhou and Christopher Hensley
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251629;
  • You have access
    Development of [68Ga]aMSLN-Fab: A Novel ImmunoPET Tracer for the Specific Diagnosis of Pancreatic Cancer
    Yueling Deng, Xiao Zhang, Xiaoying Lv, Zhaoguo Lin, Rui An, Yongxue Zhang, Jianwei Zhu, Dawei Jiang and Xiaoli Lan
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251705;
  • You have access
    177Lu-Microspheres as facile and biocompatible permanent micro-seed implants for Intra-operative and Intra-tumoral Radionuclide Therapy in breast carcinoma: A proof-of-concept preclinical study
    Sejal Chopra, Aarti Aggarwal, Komalpreet Kaur, Ajay Kumar, Amanjit Bal, Arun Oinam, Bhagwant Mittal and Jaya Shukla
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251723;
  • You have access
    A Novel Nanomedicine Radiotracer, Selectively Targeting Tumor Associated Macrophages
    Jeffrey Cleland, S. sakura Minami, Mehdi Paborji, William Thomas, Md ashraful Islam, Anja Brus, Jacob Hald and Rikke Stagaard
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251301;
  • You have access
    Cerenkov radiation-mediated photodynamic therapy remodels the extracellular matrix of pancreatic tumor for enhancing chemotherapy
    Weiwei Su, Shuai Zhao, Tao Wang, Shuping Li and Changjing Zuo
    Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251508;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
SNMMI

© 2025 SNMMI

Powered by HighWire